BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15688408)

  • 1. Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis.
    Neumann AS; Lyons HJ; Shen H; Liu Z; Shi Q; Sturgis EM; Shete S; Spitz MR; El-Naggar A; Hong WK; Wei Q
    Int J Cancer; 2005 May; 115(1):131-6. PubMed ID: 15688408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.
    Safarinejad MR; Shafiei N; Safarinejad S
    Prostate; 2010 Nov; 70(15):1645-57. PubMed ID: 20564317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men.
    Safarinejad MR; Shafiei N; Safarinejad S
    Med Oncol; 2011 Dec; 28 Suppl 1():S398-412. PubMed ID: 21046286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms and haplotypes in methylenetetrahydrofolate reductase gene and head and neck squamous cell carcinoma risk.
    Galbiatti AL; Ruiz MT; Rodrigues JO; Raposo LS; Maníglia JV; Pavarino ÉC; Goloni-Bertollo EM
    Mol Biol Rep; 2012 Jan; 39(1):635-43. PubMed ID: 21556759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms in oral squamous cell carcinoma in south-east Iran.
    Miri-Moghaddam E; Saravani S; Garme Y; Khosravi A; Bazi A; Motazedian J
    J Oral Pathol Med; 2016 Feb; 45(2):96-100. PubMed ID: 26218632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
    Safarinejad MR; Shafiei N; Safarinejad S
    Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.
    Chou YC; Wu MH; Yu JC; Lee MS; Yang T; Shih HL; Wu TY; Sun CA
    Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allele and Genotype Frequencies of the Polymorphic Methylenetetrahydrofolate Reductase and Lung Cancer in ther Jordanian Population: a Case Control Study.
    Al-Motassem Y; Shomaf M; Said I; Berger S; Ababneh N; Diab O; Obeidat N; Awidi A
    Asian Pac J Cancer Prev; 2015; 16(8):3101-9. PubMed ID: 25921104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study.
    Shen H; Spitz MR; Wang LE; Hong WK; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):397-401. PubMed ID: 11319182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylenetetrahydrofolate reductase polymorphisms/haplotypes and risk of gastric cancer: a case-control analysis in China.
    Shen H; Newmann AS; Hu Z; Zhang Z; Xu Y; Wang L; Hu X; Guo J; Wang X; Wei Q
    Oncol Rep; 2005 Feb; 13(2):355-60. PubMed ID: 15643524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population.
    Kim JK; Kim S; Han JH; Kim HJ; Chong SY; Hong SP; Hwang SG; Ahn JY; Cha KY; Oh D; Kim NK
    Anticancer Res; 2005; 25(3B):2249-52. PubMed ID: 16158971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck.
    Li G; Liu Z; Sturgis EM; Shi Q; Chamberlain RM; Spitz MR; Wei Q
    Carcinogenesis; 2005 Sep; 26(9):1596-602. PubMed ID: 15878916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary folate intake, MTHFR genetic polymorphisms, and the risk of endometrial cancer among Chinese women.
    Xu WH; Shrubsole MJ; Xiang YB; Cai Q; Zhao GM; Ruan ZX; Cheng JR; Zheng W; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):281-7. PubMed ID: 17301261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-carbon metabolism-related gene polymorphisms and risk of head and neck squamous cell carcinoma: case-control study.
    Suzuki T; Matsuo K; Hasegawa Y; Hiraki A; Wakai K; Hirose K; Saito T; Sato S; Ueda R; Tajima K
    Cancer Sci; 2007 Sep; 98(9):1439-46. PubMed ID: 17596206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between 11 genetic polymorphisms in folate-metabolising genes and head and neck cancer risk.
    Galbiatti AL; da Silva LM; Ruiz-Cintra MT; Raposo LS; Maníglia JV; Pavarino EC; Goloni-Bertollo EM
    Eur J Cancer; 2012 Jul; 48(10):1525-31. PubMed ID: 22051736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer.
    Boccia S; Boffetta P; Brennan P; Ricciardi G; Gianfagna F; Matsuo K; van Duijn CM; Hung RJ
    Cancer Lett; 2009 Jan; 273(1):55-61. PubMed ID: 18789576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population.
    Song C; Xing D; Tan W; Wei Q; Lin D
    Cancer Res; 2001 Apr; 61(8):3272-5. PubMed ID: 11309278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck.
    Zhang Z; Shi Q; Sturgis EM; Spitz MR; Hong WK; Wei Q
    Clin Cancer Res; 2004 Dec; 10(23):7903-10. PubMed ID: 15585623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between methylene-tetrahydrofolate reductase gene polymorphisms and chronic myeloid leukemia].
    Dorgham S; Aberkane M; Boughrara W; Antar Soltan B; Mehalhal N; Touhami H; Sidimansour N; Merad Boudia N; Louhibi L; Boudjema A
    Bull Cancer; 2014 Sep; 101(9):803-7. PubMed ID: 25036376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head and neck cancer susceptibility: a genetic marker in the methylenetetrahydrofolate reductase gene.
    Kureshi N; Ghaffar S; Siddiqui S; Salahuddin I; Frossard PM
    ORL J Otorhinolaryngol Relat Spec; 2004; 66(5):241-5. PubMed ID: 15583437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.